Carmell Cosmetics has introduced a new line of bio-aesthetic skin care products featuring regenerative technology. The company’s innovative approach centers around its proprietary Carmell Secretome, which utilizes Human Platelet Enriched Plasma (PRP) to create shelf-stable, regenerative skin care solutions.
This technology, developed over seven years in collaboration with Carnegie Mellon University, aims to work in harmony with the skin’s natural biological processes.
“The development of Carmell Secretome involved over seven years of rigorous research in collaboration with Carnegie Mellon University and over $60 million developing the science,” shared Kendra Bracken-Ferguson, CEO of Carmell Corporation.
The products are designed to address common skin concerns such as inflammation, pigmentation, and texture by leveraging over 1,000 growth factors, proteins, peptides, and bio-lipids.
Carmell’s commitment to clinical validation and clean formulations sets it apart in the industry, with significant improvements in skin health observed in studies.
